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Objectives The authors used multidetector computed tomography (MDCT) to study the relation between culprit plaque char-
acteristics and cardiac troponin T (cTnT) elevation after percutaneous coronary intervention (PCI).
Background Percutaneous coronary intervention is often complicated by post-procedural myocardial necrosis manifested by
elevated cardiac biomarkers.
Methods Stable angina patients (n  107) with normal pre-PCI cTnT levels underwent 64-slice MDCT before PCI to evalu-
ate plaque characteristics of culprit lesions. Patients were divided into 2 groups according to presence (group I,
n  36) or absence (group II, n  71) of post-PCI cTnT elevation 3 times the upper limit of normal (0.010
ng/ml) at 24 h after PCI.
Results Computed tomography attenuation values were significantly lower in group I than in group II (43.0 [26.5 to 75.7]
HU vs. 94.0 [65.0 to 109.0] HU, p  0.001). Remodeling index was significantly greater in group I than in group II
(1.20  0.18 vs. 1.04  0.15, p  0.001). Spotty calcification was observed significantly more frequently in group I
than in group II (50% vs. 11%, p  0.001). Multivariate analysis showed presence of positive remodeling (remodeling
index 1.05; odds ratio: 4.54; 95% confidence interval: 1.36 to 15.9; p  0.014) and spotty calcification (odds ratio:
4.27; 95% confidence interval: 1.30 to 14.8; p  0.016) were statistically significant independent predictors for cTnT
elevation. For prediction of cTnT elevation, the presence of all 3 variables (CT attenuation value 55 HU; remodeling
index 1.05, and spotty calcification) showed a high positive predictive value of 94%, and their absence showed a
high negative predictive value of 90%.
Conclusions MDCT may be useful in detecting which lesions are at high risk for myocardial necrosis after PCI. (J Am Coll
Cardiol 2012;59:1881–8) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.01.051Percutaneous coronary intervention (PCI) may be compli-
cated by post-procedural myocardial injury/infarction as
manifested by elevated cardiac biomarkers such as creatine
kinase-myocardial band or troponin T. The occurrence of
post-procedural myocardial injury/infarction has been
shown to be associated with worse short- and long-term
clinical outcome (1,2), and even mild elevation of cardiac
troponin after PCI has been related to a worse prognosis (3).
Intravascular ultrasonography (IVUS) has shown that post-
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2011, accepted January 3, 2012.procedural myocardial injury/infarction is caused by lesions
with ruptured plaques and/or those with a greater plaque
burden (4). Virtual histology IVUS also has shown that
post-PCI cardiac troponin (cTnT) elevation occurs in le-
sions with a large necrotic core area and positive remodeling
(PR) of the vessel (5).
See page 1889
Multidetector computed tomography (MDCT) is a
promising technique for noninvasive coronary angiography.
With the development of MDCT, it is possible not only to
detect coronary artery stenosis (6,7) but also to evaluate
coronary plaque quality and quantity such as can be done
with IVUS (8,9). Motoyama et al. (10) showed that the
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characteristics of culprit lesions in
acute coronary syndrome (ACS) in-
cluded PR, low-attenuation plaques,
and spotty calcification, and that the
patients with these 2 plaque charac-
teristics of PR and low-attenuation
plaques on CT angiography were at
a higher risk of developing ACS
than were patients without these
characteristics during follow-up
(11). Recently, Uetani et al. (12)
reported that post-procedural myo-
cardial injury/infarction was associ-
ated with the volume and fraction
of low-attenuation plaques de-
tected by MDCT. However, a pre-
vious study exploring potential
prognostic predictors of cardiovas-
cular events on MDCT showed
that mixed lesions were associated
with adverse events on follow-up
(13). Thin-cap fibroatheromas on
virtual histology IVUS were most
prevalent in mixed plaques, sug-
gesting a higher degree of vulner-
ability of these mixed plaques on MDCT (14).
Therefore, we hypothesized that the plaque with MDCT
characteristics of low attenuation plaques, PR, and spotty
calcification has the potential to predict an elevation of cTnT
after PCI. The aim of this study was to investigate the
clinical value of PR and spotty calcification in conjunction
with low-attenuation plaques on MDCT to predict post-
PCI cTnT elevation.
Methods
Study population. The study population comprised 107
patients who were diagnosed as having stable coronary
artery disease by 64-slice MDCT before PCI from April
2009 to August 2010 at our institution. We included
patients with stable angina pectoris (SAP) with normal
pre-PCI cTnT levels (15) and excluded patients with
ST-segment elevation myocardial infarction and unstable
AP. We also excluded patients with severely calcified
lesions, motion artifacts, previously stented lesions, and
chronic total occlusions, for which coronary plaque quantity
and degree of stenosis are difficult to evaluate by MDCT.
Study protocol. All patients underwent 64-slice MDCT to
evaluate coronary plaque characteristics of the culprit lesion
before PCI and serial measurements of cTnT before PCI
and at 24 h post-procedure. According to cTnT blood test
results, the patients were divided into 2 groups according to
the presence (group I, n  36) or absence (group II, n  71)
of post-PCI TnT elevation 3 times the upper limit of
Abbreviations
and Acronyms
ACS  acute coronary
syndrome(s)
CSA  cross-sectional area
CT  computed tomography
cTnT  cardiac troponin T
EEM  external elastic
membrane
IVUS  intravascular
ultrasonography
MDCT  multidetector
computed tomography
NPV  negative predictive
value
PCI  percutaneous
coronary intervention
PPV  positive predictive
value
PR  positive vessel
remodeling
RI  remodeling index
SAP  stable angina
pectorisnormal (0.010 ng/ml) at 24 h after PCI. 2MDCT protocol. Scanning was performed with a Philips
Brilliance-64 scanner (Philips Medical Systems, Cleveland,
Ohio) with 64  0.625-mm detector configuration. Scan-
ning was performed at 120 kV and 600 to 1,050 mA, 0.2
pitch, and with standard or sharp filters. Estimated effective
radiation dose was 11 mSv. Reconstruction was routinely
performed using a window centered at 75% of the R-R
interval to coincide with left ventricular diastasis. A volume
of 60 ml of contrast agent (iopamidol 370 mg/ml; Schering
AG, Berlin, Germany) was injected intravenously at a rate
of 4 ml/s. As soon as the signal density level in the
ascending aorta reached a pre-defined threshold of 100
Hounsfield units (HU), acquisition of CT data and an
electrocardiogram trace were automatically started during a
7-s to 9-s breath-hold. The patients were given oral
metoprolol (20 mg) 1 h before the scheduled scan if their
heart rate was 70 beats/min, and all patients received
sublingual nitroglycerin (0.3 mg) 5 min before the scan.
MDCT analysis. Analysis of the scans was performed
using a Brilliance Workspace 3-D workstation (Philips
Medical Systems). Images were initially reconstructed at
mid-diastolic phase (75% of R-R interval) of the cardiac
cycle. In some cases, additional reconstructions were made
at different time points of the R-R interval. Each scan was
analyzed independently by 2 experienced readers unaware of
the patient’s identity, clinical presentation, biomarker anal-
ysis, and PCI procedure. Image display settings for lumen
and plaque quantification were determined according to
previously published data (16).
We measured the vessel diameter and lesion length, the
cross-sectional area (CSA) of the external elastic membrane
(EEM) and target lesion, and the lumen CSA of the
proximal and distal vessel references using axial images and
multiplanar reconstruction images. The CT density values
of the culprit plaque were measured from at least 3 points,
and averaged this. Remodeling index (RI) was defined as
the EEM CSA of the target lesion divided by the average of
the EEM CSAs of the proximal and distal references. We
assessed adherent calcium deposits in or adjacent to each
plaque by determining their presence or absence and mor-
phology as follows according to previously described meth-
ods: diffuse, length of calcium burden 3/2 of vessel
diameter and width 2/3 of vessel diameter; medium,
length 3/2 of vessel diameter and width 2/3 of vessel
diameter or length 3/2 of vessel diameter and width 2/3
f vessel diameter; and spotty, length 3/2 of vessel
iameter and width 2/3 of vessel diameter (17). We
lassified the plaque into 3 types, namely, noncalcified,
alcified, and mixed plaque (18). A ringlike enhancement
as defined as either the presence of a ring of high
ttenuation around certain coronary artery plaques or the
T attenuation of a ring presenting higher than those of the
djacent plaque and no greater than 130 HU (19).
CI procedures. All patients received treatment with as-
irin (200 mg/day) and clopidogrel (75 mg/day) at least
4 h before the procedure. A glycoprotein IIb/IIIa receptor
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performed through either the radial or femoral artery using
a 6-F catheter. Before starting the procedure, 6,000 to
10,000 U of heparin were given intravenously, and the
activated clotting time was maintained at 300 s. Once the
guide wire passed through the culprit lesion, balloon dila-
tion or stent placement was performed. The treatment was
regarded as successful when the luminal diameter of the
target lesion increased by at least by 50%, residual stenosis
was less than 30%, and the TIMI (Thrombolysis In Myo-
Clinical Characteristics of the Study PopulationTable 1 Clinical Characteristics of the Stud
Characteristic
Group I (cTnT E
(n 
Age, yrs 64
Male 30 (83
Hypertension 22 (61
Dyslipidemia 30 (83
Diabetes mellitus 17 (47
Smoking 22 (61
LDL cholesterol, mg/dl 100.4
HDL cholesterol, mg/dl 46.9
Triglyceride, mg/dl 137 (90
C-reactive protein, mg/l 1.50 (0.6
Medications
Beta-blocker 12 (33
ACEI/ARB 17 (48
CCB 16 (45
Statin 23 (64
Values are mean  SD, n (%), median (interquartile range).
ACEI  angiotensin-converting enzyme inhibitor; ARB  angiotensin
HDL  high-density lipoprotein; IQR  interquartile range; LDL  low-de
Culprit Lesion and Procedural CharacteristicsTable 2 Culprit Lesion and Procedural Chara
Characteristic
Group I (cTnT Elevatio
(n  36)
Target vessel
LAD 21 (58%)
RCA 7 (19%)
LCX 8 (22%)
Type B2/C lesion 16 (45%)
Bifurcation 10 (28%)
Procedural characteristics
Number of stents 1.22 0.50
Stent size, mm 2.82 0.36
Transient no reflow 6 (16%)
MDCT measurements
Lesion EEM CSA, mm2 15.6 1.1
Lesion MLA, mm2 2.62 1.44
Lesion length, mm 16.7 4.2
Remodeling index 1.20 0.18
Positive remodeling 29 (80%)
CT attenuation value, HU 43.0 (26.5–75.7
Ringlike enhancement 11 (31%)
Values are n (%), mean  SD, or median (interquartile range).
CSA  cross-sectional area; CT  computed tomography; cTnT  caLAD  left anterior descending; LCX  left circumflex; MDCT  multidetecto
coronary artery.cardial Infarction) flow was grade 3 (20). Transient no
reflow was defined as an angiogram showing a deterioration
of coronary flow of TIMI grade 0, 1, or 2 during the
procedure, regardless of the timing, and TIMI grade 3 at
the final angiogram (21).
Statistical analysis. All data are expressed as the mean 
D or median and interquartile range for non-normally
istributed data. Comparisons of continuous variables were
nalyzed by unpaired t test or Mann-Whitney U test
ccording to the data distribution. Comparisons of categor-
ulation
n >3) Group II (cTnT Elevation <3)
(n  71) p Value
66 9 0.219
54 (76%) 0.379
54 (76%) 0.112
55 (77%) 0.472
35 (49%) 0.671
50 (70%) 0.147
92.6 22.9 0.151
49.5 15.0 0.467
) 129 (82.5–195) 0.802
) 1.00 (0.60–2.50) 0.195
26 (37%) 0.737
34 (49%) 0.953
44 (63%) 0.125
53 (75%) 0.234
r blocker; CCB  calcium-channel blocker; cTnT  cardiac troponin T;
oprotein.
istics
) Group II (cTnT Elevation <3)
(n  71) p Value
37 (52%) 0.541
19 (26%) 0.398
15 (21%) 0.896
30 (43%) 0.789
19 (27%) 0.953
1.14 0.45 0.373
2.79 0.54 0.789
2 (3%) 0.012
14.1 0.8 0.252
2.88 1.27 0.381
14.1 5.1 0.012
1.04 0.15 0.001
24 (32%) 0.001
94.0 (65.0–109.0) 0.001
8 (11%) 0.016
roponin T; EEM  external elastic membrane; HU  Hounsfield units;y Pop
levatio
36)
10
%)
%)
%)
%)
%)
26.7
17.0
.5–195
5–3.50
%)
%)
%)
%)cter
n >3
)
rdiac t
r computed tomography; MLA  minimum lumen area; RCA  right
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test without correction for multiplicity. Interobserver and
intraobserver agreements were performed by linear regres-
sion analyses for continuous variables and kappa () test for
categorical variables. Receiver-operating characteristic anal-
ysis was used to determine optimal cutoff values of CT
attenuation value and RI for prediction of post-PCI cTnT
elevation. The best cutoff value was defined as the point
Figure 1 CT Characteristics of Culprit Lesion in Patient With P
Computed tomography (CT) characteristics of culprit lesion (arrow) in a 52-year-old
neous coronary intervention (PCI). (A) Coronary angiogram and (B) multiplanar rec
sectional images show (C) the proximal reference, (D) the culprit lesion, and (E)
spotty calcification, and low CT density (16 HU). Red circle indicates area of spot
Figure 2 CT Characteristics of Culprit Lesion in Patient Withou
Computed tomography (CT) characteristics of the culprit lesion (arrow) in a 51-yea
percutaneous coronary intervention (PCI). (A) Coronary angiogram and (B) multipla
artery. Cross-sectional images show (C) the proximal reference, (D) the culprit les
index: 0.98), and CT density is 76 HU.with the highest sum of sensitivity and specificity. Results
displayed for univariate analysis were based on clinically
relevant and laboratory-based variables and lesion charac-
teristics. Multivariate logistic regression analysis was then
developed to calculate odds ratios and 95% confidence inter-
vals. We performed stepwise forward selection considering any
valuables with values of p  0.20 to identify potential risk
factors for post-PCI cTnT elevation. The sensitivity,
CI TnT Elevation >3 Times Upper Limit of Normal
with troponin T (TnT) elevation 3 times the upper limit of normal after percuta-
cted image show severe stenosis in the mid right coronary artery. Cross-
tal reference. The lesion has positive remodeling (remodeling index: 1.28),
ification.
t-PCI TnT Elevation >3 Times Upper Limit of Normal
an without troponin T (TnT) elevation 3 times the upper limit of normal after
constructed image show significant stenosis in the mid left anterior descending
d (E) the distal reference. The lesion has no positive remodeling (remodelingost-P
man
onstru
the dis
ty calct Pos
r-old m
nar re
ion, an
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predictive value (NPV), and diagnostic accuracy of the
CT characteristics alone or in combination were calcu-
lated for prediction of post-PCI cTnT elevation. A p
value of 0.05 was considered to indicate statistical
significance.
Results
Patient, lesion, and procedural characteristics. Patients
were divided into 2 groups according to the presence (group I,
n  36) or absence (group II, n  71) of post-PCI cTnT
elevation 3 times or more (3) the upper limit of normal
(0.010 ng/ml) at 24 h after PCI. Baseline patient charac-
teristics are summarized in Table 1. There were no statis-
tically significant differences in the clinical characteristics
and medications between the 2 groups. The median post-
PCI cTnT levels were significantly higher in patients in
group I than in group II (0.088 [0.037 to 0.289] ng/ml vs.
0.010 [0.010 to 0.014] ng/ml, p  0.001). Angiographic
findings and procedural results are summarized in Table 2.
All lesions were treated with stent implantation. There were
no statistically significant differences in target vessels, type
B2/C lesions, bifurcation lesions, number of stents im-
planted, and stent size between the 2 groups. Transient no
reflow was observed significantly more frequently in group I
than in group II (16% vs. 2%, p  0.012).
MDCT measurements in the culprit lesion. Representa-
tive images from patients in groups I and II are presented in
Figures 1 and 2, respectively. Fifty randomly selected lesions
were measured by 2 observers. Interobserver and intraob-
server measurements of CT attenuation value (r 0.92, p
0.0001, and r 0.93, p 0.0001, respectively) and RI (r
0.83, p  0.0001, and r  0.87, p  0.0001, respectively)
were closely correlated, and mean differences in CT atten-
uation value (0.75  1.58 HU and 2.09  1.31 HU,
respectively) and RI (0.017  0.013 and 0.004  0.011,
respectively) were small. Agreement () for the interpreta-
tion of spotty calcification was 0.90 and 0.92, respectively.
According to the receiver-operating characteristic analysis,
the best cutoff points of CT attenuation value was 55 HU,
with a sensitivity of 69% and a specificity of 80%, and RI
was 1.05, with a sensitivity of 80% and a specificity of 68%
for prediction of post-cTnT elevation. Therefore, we de-
fined the CT attenuation value of 55 HU as the lower
plaque density and RI of 1.05 as the PR. Lesion charac-
teristics on MDCT are listed in Table 2. The CT attenu-
ation value of the culprit plaque was significantly lower in
group I than in group II (43.0 [26.5 to 75.7] HU vs. 94.0
[65.0 to 109.0] HU, p  0.001), and presence of PR (80%
vs. 32%, p  0.001) and lesion length (16.7  4.2 mm vs.
14.1  5.1 mm, p  0.012) were significantly greater in
group I than in group II. The prevalence of any coronary
plaque subtype and any calcified subtype with the presence
or absence of post-PCI cTnT elevation is in Figure 3.
Mixed plaques (64% vs. 31%, p  0.001) and spottycalcification (50% vs. 11%, p  0.001) were observed
significantly more frequently in group I than in group II,
whereas noncalcified plaques (33% vs. 61%, p 0.001) were
observed significantly less frequently in group I than in
group II. Plaque with ringlike enhancement was observed
significantly more frequently in group I than in group II
(31% vs. 11%, p  0.016).
Univariate and multivariate analysis for predicting post-
PCI cTnT elevation. Post-PCI cTnT elevation was
observed in 36 of the 107 patients (33.6%) in this study.
According to the univariate analysis (Table 3), lesion
length, PR, CT attenuation, and spotty calcification were
significantly associated with post-PCI cTnT elevation.
Figure 3 Percentage of Patients With Any
Plaque Subtype and Any Calcified Type
Percentage of patients with (A) any plaque subtype and (B) any calcified type,
according to the presence or absence of cardiac troponin T (cTnT) elevation 3
times the upper limit of normal (3) after percutaneous coronary intervention
(PCI). Open bars  cTnT 3; solid bars  cTnT 3. CP  calcified plaque;
MP  mixed plaque; NCP  noncalcified plaque.Multiple logistic regression analysis showed that the
RI  re
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val: 1.36 to 15.9; p  0.014) and spotty calcification
(odds ratio: 4.27; 95% confidence interval: 1.30 to 14.8;
p  0.016) were statistically significant independent
predictors for post-PCI cTnT elevation after adjustment
for multiple confounders.
Diagnostic accuracy of CT characteristics for predicting
post-PCI cTnT elevation. The sensitivity, specificity,
PPV and NPV, and diagnostic accuracy of each CT
characteristic alone or in combination are shown in Table 4.
Presence of all 3 characteristics (CT 55 HU, RI 1.05,
and spotty calcification) showed a high PPV of 94%, and
absence of all 3 showed a high NPV of 90% for predictive
value of cTnT elevation.
Discussion
Importantly, our study demonstrated a direct relation be-
tween pre-PCI plaque composition by MDCT and post-
procedural myocardial injury/infarction in SAP patients.
Post-PCI cTnT elevation 3 the upper limit of normal
was observed in 33.6% of patients with SAP. The presence
of positive remodeling and spotty calcification were the
significant predictors of post-PCI cTnT elevation. For
prediction of post-PCI cTnT elevation, the presence of all
3 CT characteristics showed a high PPV of 94%, and their
absence offered a high NPV of 90% for the exclusion of
culprit lesions by noninvasive MDCT imaging.
Univariate and Multivariate Logistic Regressionfor Predictio of Cardiac Troponin ElevationTable 3 Univariate and Multivariate L gisticfor Prediction of Cardiac Troponin E
Univariate Analysi
Factor OR 95% CI
Age 1.03 0.98–1.08
EEM CSA 1.04 0.96–1.12
Lesion length 1.12 1.02–1.23
RI 1.05 8.65 3.45–24.2
CT value 55 HU 9.25 3.79–24.1
Spotty calcification 7.04 2.71–19.7
Log CRP 1.29 0.48–1.22
Statin use 0.57 0.22–1.44
CI  confidence interval; CRP  C-reactive protein; OR  odds ratio;
Diagnostic Accuracy of CT Characteristicsfor Prediction of Cardiac roponin ElevationTable 4 Diagnost c Accuracy of CT Charactfor Prediction of Cardiac Troponin E
Factor Sens
CT value 55 HU
RI 1.05
Spotty calcification
CT value 55 HU  RI 1.05
CT value 55 HU  RI 1.05  spotty calcification
CT value 55 HU or RI 1.05
CT value 55 HU or RI 1.05 or spotty calcificationNPV  negative predictive value; PPV  positive predictive value; other abbrRelation between plaque characteristics on MDCT and
cTnT elevation. Cardiac biomarker cTnT is sensitive and
specific for detection of myocardial damage. Porto et al. (22)
found that the cause of periprocedural myocardial necrosis
after PCI was the impairment of flow in coronary side
branches and distal embolization of atheromatous or throm-
botic materials. Therefore, pre-PCI plaque composition
may have an impact on myocardial injury/infarction during
PCI. However, there are few published data regarding the
relation between pre-PCI plaque composition by MDCT
and post-PCI cardiac biomarker levels. Nakazawa et al. (23)
reported that patients who experienced transient no reflow
during PCI had lower plaque CT density values in culprit
lesions. Uetani et al. (12) demonstrated that post-procedural
myocardial injury was associated with the volume and fraction
of low-attenuation plaques by MDCT. In the present study, CT
attenuation value of 55 HU was associated with post-PCI
cTnT elevation.While in earlier studies, ameanCTdensity of 14
to 47 HU was found in lipid-rich plaque (8,24,25), Pohle et al.
(26) showed a mean density of 58 HU (median 53), and Leber et
al. (16) reported that a low CT density value (49  22 HU) is
considered to correspond to soft plaque identified on IVUS.
This difference most likely results from the natural course of
atherosclerotic plaque or slice thickness and contrast me-
dium concentration that affect plaque density measurements
(27,28). It will be possible to use our cutoff point of CT
attenuation value 55 HU for prediction of post-PCI
cTnT elevation clinically.
ysesres ion Analyses
ion
Multivariate Analysis
Value OR 95% CI p Value
0.161 1.02 0.96–1.07 0.522
0.272
0.012 1.07 0.97–1.20 0.187
0.001 4.54 1.36–15.9 0.014
0.001 2.03 0.57–7.05 0.265
0.001 4.27 1.30–14.8 0.016
0.271
0.237
modeling index; other abbreviations as in Table 2.
cs
ion
(%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
80 64 84 77
68 56 87 72
88 69 78 76
85 69 83 79
98 94 79 81
63 54 88 70
58 52 90 68AnalReg
levat
s
p


eristi
levat
itivity
69
80
50
67
47
83
86eviations as in Tables 2 and 3.
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resent study, PR and spotty calcification were significant
redictors of post-PCI cTnT elevation. Furthermore, pres-
nce of all 3 CT characteristics (CT attenuation value 55
U, RI1.05, and spotty calcification) showed a high PPV
f 94%, and their absence showed a high NPV of 90%. The
R has been associated with plaque vulnerability in clinical
tudies. A previous report of an IVUS study confirmed that
R (RI 1.05) was an important factor in the culprit lesion
29). Histopathological characteristics of ruptured plaques
howed the same characteristics of the vulnerable plaques.
laque rupture occurred not only in patients with unstable
ngina pectoris or myocardial infarction but also in those
ith SAP. The rupture site has larger arterial wall and
umen areas and more PR (30). Another histopathological
eport showed that coronary plaques with PR had a higher
ipid content and macrophage count (31), which indicated
laque vulnerability. Ehara et al. (32) found by IVUS study
hat small calcium deposits were present with significant
requency in the culprit lesion segments in patients with
CS. Burke et al. (33) reported that autopsy data showed
he degree of calcification was greatest for acute and healed
laque ruptures and the least for plaque erosion. Calcifica-
ion in coronary atherosclerosis is associated with 1 type of
laque instability, namely, plaque rupture (33).
The data in the present study showed that some SAP
atients have spotty calcification and that plaque with spotty
alcification was 1 of the predictors of post-PCI cTnT
levation. A previous MDCT study showed that mixed
esions were associated with adverse events on follow-up
13). Thin-cap fibroatheromas on virtual histology IVUS
ere most prevalent in mixed plaques, suggesting a higher
egree of vulnerability of these mixed plaques on MDCT
14). In the present study, we found that mixed plaques with
ow-attenuation plaques, PR, and spotty calcification have
he potential to predict an elevation of cTnT after PCI. We
lso demonstrated that none of the conventional risk factors
llowed differentiation between the post-PCI cTnT eleva-
ion and the elevation-free group. These findings were in
greement with a previous MDCT study by Motoyama et
l. (11), and were also supported by recent near-infrared
pectroscopy data (34).
linical implications. These data suggest that it would be
orthwhile to consider the identification of these vulnerable
laques by MDCT before PCI. If the plaque has the
haracteristics of low plaque density, PR, and spotty calci-
cation, a plan for prevention of post-PCI cTnT elevation
an be made before the PCI procedure. Further efforts to
inimize procedural events may require aggressive attempts
o prevent distal embolization (35). As for medications,
awai et al. (36) reported that intravenous administration of
icorandil before PCI can prevent slow coronary flow
henomenon. A single high loading dose (80 mg) of
torvastatin administered within 24 h of PCI reduces the
ncidence of periprocedural MI in elective PCI (37). There-
ore, the use of these medicines during or before therocedure might the possibility of preventing post-
rocedural myocardial injury/infarction in the perioperative
eriod.
tudy limitations. First, we acknowledge that because of
he relatively small sample size in the present study, our
ndings should be confirmed in a larger number of patients.
econd, we excluded patients with severely calcified lesions
n this study. In general, SAP patients frequently have more
evere coronary artery calcification in their coronary arteries
han do ACS patients. If we included these patients in this
tudy, it is probable that the occurrence of post-PCI cTnT
levation would be lower than that of our presented data.
hird, CT plaque density can be altered by the concentra-
ion of the contrast agent administered or by contrast type,
egardless of the presence or absence of calcification near the
laque and of the model of CT used. Finally, we consider it
ecessary to investigate the relation between the MDCT
mage and histopathology and to confirm the correspon-
ence between these imaging characteristics and histo-
athologic findings.
onclusions
he present MDCT study showed that post-PCI cTnT
levation occurred in lesions with low-attenuation plaques,
R, and spotty calcification in patients with SAP. MDCT
ay play an important role in detecting which lesions are at
igh risk for myocardial necrosis after PCI.
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